NVX — Novonix Income Statement
0.000.00%
- AU$249.89m
- AU$295.10m
- $5.85m
Annual income statement for Novonix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | R2022 June 30th | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | fx Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3.38 | 4.55 | 7.7 | 8.05 | 5.85 |
Cost of Revenue | |||||
Gross Profit | -0.186 | -0.53 | -6.76 | -15.1 | -19.5 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 13.2 | 17.8 | 55.1 | 58.1 | 60.3 |
Operating Profit | -9.85 | -13.2 | -47.4 | -50.1 | -54.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -13.4 | -13.5 | -51.9 | -46.4 | -74.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -13.4 | -13.5 | -51.9 | -46.2 | -74.8 |
Net Income Before Extraordinary Items | |||||
Net Income | -13.4 | -13.5 | -51.9 | -46.2 | -74.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -13.4 | -13.5 | -51.9 | -46.2 | -74.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.099 | -0.031 | -0.103 | -0.095 | -0.151 |